| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/08/1998 | EP0833632A1 Method to increase retinal blood flow |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833612A1 New pharmaceutical composition with anaesthetic effect |
| 04/08/1998 | EP0833611A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 04/08/1998 | EP0703731B1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 04/08/1998 | CN1178466A Antitumor agents comprising as the principal agent compounds |
| 04/08/1998 | CN1178463A Use of anti-oestrogens as male contraceptives |
| 04/08/1998 | CN1178461A Pharmaceutical compositions comprising monoamine oxidase B inhibitors |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |
| 04/07/1998 | US5736531 Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| 04/07/1998 | US5736527 Synergistic mixture |
| 04/07/1998 | US5736526 Mixed reverse trascriptase inhibitor and hydroxyurea for treatment of hiv virus |
| 04/07/1998 | US5736525 Used for treatemnt of acquired immuno deficiency syndrome with anti-aids drugs selected from 3'-azido-3'-deoxythymidine(azt), dideoxyinosine(ddi), or dideoxycytidine(ddc) |
| 04/07/1998 | US5736396 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/07/1998 | US5736151 Antibiotic oil suspensions |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013475A1 Methods for culturing cells |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013073A1 METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN |
| 04/02/1998 | WO1998013066A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013047A1 Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives |
| 04/02/1998 | WO1998013046A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 04/02/1998 | WO1998013044A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors |
| 04/02/1998 | WO1998013042A1 Antimycotic gel with high active substance release |
| 04/02/1998 | WO1998013040A1 Eyedrops |
| 04/02/1998 | WO1998013026A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
| 04/02/1998 | WO1998005292A3 Piperidine and piperazine derivatives and their use as muscarinic antagonists |
| 04/02/1998 | DE19640555A1 Use of isoxazole-amide or croton-amide derivatives to modulate apoptosis |
| 04/02/1998 | DE19640364A1 Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen Topical agents for the prophylaxis or treatment of bacterial skin infections |
| 04/02/1998 | DE19639816A1 Antimykotische Mittel mit hoher Wirkstofffreisetzung Antifungal agent with high drug release |
| 04/02/1998 | CA2268945A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 04/02/1998 | CA2267332A1 Methods for culturing cells |
| 04/02/1998 | CA2264544A1 Snrnp sm proteins |
| 04/02/1998 | CA2264158A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors |
| 04/02/1998 | CA2264043A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 04/02/1998 | CA2263134A1 Cytotoxic peptides |
| 04/02/1998 | CA2236154A1 Novel creba isoform |
| 04/01/1998 | EP0832977A2 Novel sugar kinase |
| 04/01/1998 | EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus |
| 04/01/1998 | EP0832973A2 GTP-binding protein |
| 04/01/1998 | EP0832289A1 Novel gene-up regulated in regenerating liver |
| 04/01/1998 | EP0832224A1 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832205A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832198A1 Oxygen activatable formulations for disinfection or sterilization |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832060A1 Chalcone retinoids and methods of use of same |
| 04/01/1998 | EP0831932A1 Novel targeted compositions for diagnostic and therapeutic use |
| 04/01/1998 | EP0831911A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831910A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831906A1 Treatment of t cell mediated autoimmune disorders |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831892A1 Multimeric, recombinant urease vaccine |
| 04/01/1998 | EP0831891A1 Oxidant scavengers |
| 04/01/1998 | EP0831887A1 Therapy using lymphotoxin and thrombopoietin |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831883A1 Treatment of alzheimer disease by modulation of synapsins |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831876A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 04/01/1998 | EP0831875A1 Methods of inhibiting phagocytosis |
| 04/01/1998 | EP0831873A1 The treatment of hiv and other viral infections using combinatory therapy |
| 04/01/1998 | EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 04/01/1998 | EP0831858A1 Intrauterine chemical necrosing method and composition |
| 04/01/1998 | EP0831857A2 Phosphate-binding polymers for oral administration |
| 04/01/1998 | EP0831856A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 04/01/1998 | EP0831853A1 Augmented atp production |
| 04/01/1998 | EP0831849A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 04/01/1998 | EP0831840A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
| 04/01/1998 | EP0831834A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis |
| 04/01/1998 | EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 04/01/1998 | EP0831824A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/01/1998 | EP0831821A1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 04/01/1998 | EP0831819A1 Method for inhibiting neoplastic disease in mammals |
| 04/01/1998 | EP0831818A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 04/01/1998 | EP0831817A1 Antigen-processing cell-targeted conjugates |
| 04/01/1998 | EP0831808A1 Osteogenetic promoting pharmaceutical composition |
| 04/01/1998 | EP0831806A1 Multidentate metal complexes and methods of making and using thereof |
| 04/01/1998 | EP0831802A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs |
| 04/01/1998 | EP0831801A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork |
| 04/01/1998 | EP0831796A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors |
| 04/01/1998 | EP0831769A2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 04/01/1998 | EP0831767A1 Alpha hydroxyacid esters for skin aging |
| 04/01/1998 | EP0831728A2 Mineral supplements for dietetic food |
| 04/01/1998 | EP0831726A1 Health food product |
| 04/01/1998 | EP0453515B1 Composition for treatment of senile dementia |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 04/01/1998 | CN1177921A Medicated tissue paper product |
| 03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
| 03/31/1998 | US5733902 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
| 03/31/1998 | US5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 03/31/1998 | US5733726 Cytotoxicity-based genetic selection system (TOXSEL) |